Detalhe da pesquisa
1.
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
Am J Hematol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751104
2.
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.
Leukemia
; 38(4): 762-768, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378841
3.
Effect of acute altitude exposure on physiological parameters and glucose metabolism in healthy lowland Peruvians.
F1000Res
; 12: 724, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981980
4.
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
J Mol Diagn
; 25(9): 665-681, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419244
5.
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.
Blood Cancer Discov
; 3(2): 116-135, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015684
6.
Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
Hematol Oncol Clin North Am
; 32(4): 643-655, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047417